Diabetic sensorimotor polyneuropathy (DSPN) research hub

Efficacy and safety of a combined therapy with Alpha-Lipoic Acid and Benfotiamine in the symptomatic treatment of diabetic sensorimotor polyneuropathy - a prospective, randomized, controlled, parallel group, double-blind, double-dummy 3-arm trial

This study is testing if a combination of two medicines, alpha-lipoic acid and benfotiamine, can help people with nerve damage from diabetes. Researchers want to see if this treatment improves symptoms and is safe to use.